Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
465396017 | Rifampicin+isoniazid 150mg/100mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
717962010 | Rifampicin+isoniazid 150mg/100mg tablet (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
1190388013 | Rifampicin+isoniazid 150mg/100mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
3471016014 | Product containing rifampin 150 mg and isoniazid 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3471017017 | Product containing rifampicin 150 mg and isoniazid 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3484061015 | Product containing rifampicin 150 mg and isoniazid 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
3500704015 | Rifampicin 150 mg and isoniazid 100 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3500705019 | Rifampin 150 mg and isoniazid 100 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3566540019 | Product containing only rifampicin 150 mg and isoniazid 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3566541015 | Product containing only rifampin 150 mg and isoniazid 100 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3566542010 | Product containing only rifampicin 150 mg and isoniazid 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
3682659018 | Isoniazid 100 mg and rifampin 150 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3682660011 | Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3682661010 | Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3682662015 | Isoniazid 100 mg and rifampicin 150 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
46695501000001111 | Rifampicin 150mg / Isoniazid 100mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Is a | Product containing isoniazid and rifampicin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Rifampicin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrazine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Isoniazid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Is a | Product containing rifampicin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Is a | Product containing isoniazid in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Is a | Product containing isoniazid and rifampicin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Isoniazid | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has basis of strength substance | Isoniazid | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Rifampicin | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has basis of strength substance | Rifampicin | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has basis of strength substance | Rifampicin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has basis of strength substance | Isoniazid | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has precise active ingredient | Rifampicin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has precise active ingredient | Isoniazid | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Is a | Product containing only isoniazid and rifampicin in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Isoniazid | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has active ingredient | Rifampicin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Is a | Rifampicin + Isoniazid | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has specific active ingredient | Rifampicin | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has specific active ingredient | Isoniazid | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Rifampicin+isoniazid 150mg/100mg tablet - product | Is a | False | Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Rifinah 150 tablets (Aventis Pharma) | Is a | True | Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Rimactazid 150 tablets (Healthcare Logistics) | Is a | True | Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Rifampicin 150mg / Isoniazid 100mg tablets 84 tablet | Is pack of | False | Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Rifampicin 150mg / Isoniazid 100mg tablets 84 tablet | Has VMP | True | Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets